Preparation and properties of inhalable nanocomposite particles: Effects of the temperature at a spray-dryer inlet upon the properties of particles

Colloids and Surfaces B: Biointerfaces

Volumn 61, Issue 2, 2008, Pages 138-144

  Tomoda, Keishiro ^a   Ohkoshi, Takumi ^a   Kawai, Yusaku ^a   Nishiwaki, Motoko ^a   Nakajima, Takehisa ^a   Makino, Kimiko ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Inhalation; Nanocomposite; Nanoparticle; PLGA; Rifampicin; Spraydry

Indexed keywords

FINAL CONTROL DEVICES; NANOPARTICLES; SONICATION; SPRAY DRYING; SUGAR (SUCROSE);

FINE PARTICLE FRACTION (FPF); INHALATION; RIFAMPICIN; SPRAYDRY;

NANOCOMPOSITES;

DRUG ADDITIVE; LACTOSE; NANOCOMPOSITE; NANOPARTICLE; POLYGLACTIN; RIFAMPICIN; SUGAR; TREHALOSE;

ARTICLE; DEVICE; DRUG DELIVERY SYSTEM; DRY POWDER; INHALATION; INHALER; LIGHT SCATTERING; LUNG; LUNG ALVEOLUS; LUNG DISEASE; NANOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TEMPERATURE; THERMAL ANALYSIS; ULTRACENTRIFUGATION;

ADMINISTRATION, INHALATION; CALORIMETRY, DIFFERENTIAL SCANNING; CARBOHYDRATES; LACTIC ACID; NANOCOMPOSITES; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; RIFAMPIN; TEMPERATURE; WATER;

EID: 37549031760     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2007.07.016     Document Type: Article

References (21)

1. Agu R.U., Ugwoke M.I., Armand M., Kinget R., and Verbeke N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir. Res. 2 (2001) 198-209
2. Zeng X.M., Martin G.P., and Marriott C. The controlled delivery of drugs to the lung. Int. J. Pharm. 124 (1995) 149-164
3. Patton J.S. Unlocking the opportunity of tight glycaemic control, innovative delivery of insulin via the lung. Diabetes Obes. Metab. 7 (2005) S5-S8
4. 2-enriched air: pharmacokinetic studies. Cancer Chemother. Pharmacol. 47 (2001) 451-456
5. Bennett W.D., Brown J.S., Zeman K.L., Hu S.-C., Scheuch G., and Sommerer K. Targeting delivery of aerosols to different lung regions. J. Aerosol Med. 15 (2002) 179-188
6. Dhand R. Respiratory care clinics of North America. Future Dir. Aerosol Ther. 7 (2001) 319-335
7. Parthasarathy R., Gilbert B., and Mehta K. Aerosol delivery of liposomal all-trans-retinoic acid to the lungs. Cancer Chemother. Pharmacol. 43 (1999) 277-283
8. Sharma S., White D., Imondi A.R., Placke M.E., Vail D.M., and Kris M.G. Development of inhalational agents for oncologic use. J. Clin. Oncol. 19 (2001) 1839-1847
9. Makino K., Nakajima T., Shikamura M., Ito F., Ando S., Kochi C., Inagawa H., Soma G.-I., and Terada H. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloids Surf. B: Biointerfaces 36 (2004) 35-42
10. Ito F., and Makino K. Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres. Colloids Surf. B 39 (2004) 17-21
11. Soma G.-I., Inagawa H., and Kouchi C. The unique feature of alveolar macrophages in innate immune systems. Membrane 27 (2002) 244-251
12. Yoshida A., Matumoto M., Hashizume H., Oba Y., Tomishige T., Inagawa H., Kohchi C., Hino M., Ito F., Tomoda K., Nakajima T., Makino K., Terada H., Hori H., and Soma G.-I. Selective delivery of rifampicin incorporated into poly(d,l-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette-Guérin. Microbes Infect. 8 (2006) 2484-2491
13. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53 (2001) 283-318
14. Schürch S., Gehr P., Hof V.I., Geiser M., and Green F. Surfactant displaces particles toward the epithelium in airways and alveoli. Respir. Physiol. 80 (1990) 17-32
15. Ghirardelli R., Bonasoro F., Porta C., and Cremaschi D. Identification of particular epithelial areas and cells that transport polypeptide-coated nanoparticles in the nasal respiratory mucosa of the rabbit. Biochim. Biophys. Acta (BBA)-Biomembranes 12 (1999) 1-2
16. Huang M., Ma Z., Khor E., and Lim L.-Y. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm. Res. 19 (2002) 1488-1494
17. Russell-Jones G.J., Veitch H., and Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int. J. Pharm. 190 (1999) 165-174
18. Finlay W.H., and Gehmlich M.G. Inertial sizing of aerosol inhaled from two dry powder inhalers with realistic breath patterns versus constant flow rates. Int. J. Pharm. 210 (2000) 83-95
19. Finlay W.H., Stapleton K.W., and Zuberbuhler P. Fine particle fraction as a measure of mass depositing in the lung during inhalation of nearly isotonic nebulized aerosols. J. Aerosol Sci. 28 (1997) 1301-1309
20. K. Makino, H. Terada, T. Nakajima, K. Tomoda, JP075335, March 17, 2006.
21. Tomoda K., Kojima S., Kajimoto M., Watanabe D., Nakajima T., and Makino K. Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres. Colloids Surf. B: Biointerfaces 45 (2005) 1-6